Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors

This study has been completed.
Sponsor:
Collaborators:
Brigham and Women's Hospital
Massachusetts General Hospital
AstraZeneca
Information provided by (Responsible Party):
Judy E. Garber, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00165308
First received: September 9, 2005
Last updated: July 8, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)
No publications provided by Dana-Farber Cancer Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):